Strainprint™ Technologies has expanded their nation-wide coverage with the addition of Stewart Farms.
"Stewart Farms is a late-stage applicant headquartered in Alberta that is building a 100,000 sq. ft. vertical aquaponics farm in Saint Stephens, New Brunswick," the team with the company explains. "They will be utilizing automation, vertical farming, and land-based aquaculture to produce medical-grade organic cannabis for both recreational and medical markets in Canada. All of their products will be free of herbicides, chemical crop protections and synthetic nutrients. At full capacity, they will reach more than 10,000 kgs per year of organically farmed cannabis and more than 200,000 kgs of organic tilapia."
"Through our partnership with Strainprint we gain direct access to their data and analytics tools. This will aid us in educating a wider audience on the medical benefits and best practices of cannabis-based medicine," said Tanner Stewart, Co-founder & CEO of Stewart Farms. "We know our customers are looking to consume more than dried cannabis. We know Canadians of all legal ages are trying to sort through their personal engagement with cannabis as a medicine. What we want to know, on an ongoing basis, is what is and is not working for people. Strainprint's patient-led data services will give us the insight needed to create custom products and further understand the benefits of our existing products. Finally, our goal is to partner with companies and teams that truly have people's best interest at heart. Caring about a patient's success is what makes up the core of the Strainprint team. We couldn't be happier to move forward with them at our side."
According to the company, Stewart Farms will access the Strainprint Analytics web platform to improve product development. "Strainprint Analytics is built on top of the largest and most granular scientific data set of its kind in the world, with more than 1.3 million anonymized, patient reported medical cannabis outcomes and more than 65 million data points on strain efficacy," they explain.
"We're thrilled to provide our real-time, crowdsourced data to an environmentally conscious company that uses innovative, cutting edge farming technology to produce top-tier medical cannabis," said Strainprint CEO, Andrew Muroff.
B03 2207 90b Street SW
Edmonton, AB, Canada